BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Konski A, Meyer JE, Joiner M, Hall MJ, Philip P, Shields A, McSpadden E, Choi M, Adaire B, Duncan G, Meropol NJ, Cescon TP, Cohen SJ. Multi-institutional phase I study of low-dose ultra-fractionated radiotherapy as a chemosensitizer for gemcitabine and erlotinib in patients with locally advanced or limited metastatic pancreatic cancer. Radiother Oncol 2014;113:35-40. [PMID: 25441058 DOI: 10.1016/j.radonc.2014.08.014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Al-Rajhi NM, Khalil EM, Ahmad S, Soudy H, AlGhazi M, Fatani DM, Memon M, Abouzied M, Khafaga YM. Low-dose fractionated radiation with induction docetaxel and cisplatin followed by concurrent cisplatin and radiation therapy in locally advanced nasopharyngeal cancer: A randomized phase II-III trial. Hematol Oncol Stem Cell Ther 2021;14:199-205. [PMID: 32504593 DOI: 10.1016/j.hemonc.2020.05.005] [Reference Citation Analysis]
2 Mattoli MV, Massaccesi M, Castelluccia A, Scolozzi V, Mantini G, Calcagni ML. The predictive value of 18F-FDG PET-CT for assessing the clinical outcomes in locally advanced NSCLC patients after a new induction treatment: low-dose fractionated radiotherapy with concurrent chemotherapy. Radiat Oncol 2017;12:4. [PMID: 28057034 DOI: 10.1186/s13014-016-0737-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
3 Sindoni A, Minutoli F, Ascenti G, Pergolizzi S. Combination of immune checkpoint inhibitors and radiotherapy: Review of the literature. Crit Rev Oncol Hematol 2017;113:63-70. [PMID: 28427523 DOI: 10.1016/j.critrevonc.2017.03.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 6.5] [Reference Citation Analysis]
4 Salama AKS, Postow MA, Salama JK. Irradiation and immunotherapy: From concept to the clinic: Radiation and Immunotherapy. Cancer 2016;122:1659-71. [DOI: 10.1002/cncr.29889] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 10.0] [Reference Citation Analysis]
5 Wu Y, Gan Y, Yuan H, Wang Q, Fan Y, Li G, Zhang J, Yao M, Gu J, Tu H. Enriched environment housing enhances the sensitivity of mouse pancreatic cancer to chemotherapeutic agents. Biochemical and Biophysical Research Communications 2016;473:593-9. [DOI: 10.1016/j.bbrc.2016.03.128] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
6 Wang Q, Xiao Z, Lin Z, Zhou J, Chen W, Jie W, Cao X, Yin Z, Cheng J. Autophagy influences the low-dose hyper-radiosensitivity of human lung adenocarcinoma cells by regulating MLH1. Int J Radiat Biol 2017;93:600-6. [PMID: 28117625 DOI: 10.1080/09553002.2017.1286052] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Jin HB, Lu L, Xie L, Yang JF, Zhang XF, Ma SL. Concentration changes in gemcitabine and its metabolites after hyperthermia in pancreatic cancer cells assessed using RP-HPLC. Cell Mol Biol Lett 2019;24:30. [PMID: 31131010 DOI: 10.1186/s11658-019-0153-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
8 Jamorabo DS, Lin SH, Jabbour SK. Successes and Failures of Combined Modalities in Upper Gastrointestinal Malignancies: New Directions. Seminars in Radiation Oncology 2016;26:307-19. [DOI: 10.1016/j.semradonc.2016.05.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
9 Morganti AG, Cellini F, Mignogna S, Padula GD, Caravatta L, Deodato F, Picardi V, Macchia G, Cilla S, Buwenge M, Lullo LD, Gambacorta MA, Balducci M, Mattiucci GC, Autorino R, Valentini V. Low-dose radiotherapy and concurrent FOLFIRI-bevacizumab: a Phase II study. Future Oncology 2016;12:779-87. [DOI: 10.2217/fon.15.350] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
10 Fields EC, McGuire WP, Lin L, Temkin SM. Radiation Treatment in Women with Ovarian Cancer: Past, Present, and Future. Front Oncol 2017;7:177. [PMID: 28871275 DOI: 10.3389/fonc.2017.00177] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 7.8] [Reference Citation Analysis]